Skip to content
‹ Back to IndustriesSciences

Let the Space Race Begin Again

NASA successfully launched the most powerful rocket in the world into outer space this week. The Orion spacecraft is headed for the moon, with the goal of returning to earth in less than four weeks. The journey is the first leg of the Artemis I mission, which has the goal of eventually launching spacecraft…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Ryan Duffy · · ArtemisNasaOrionSpacelaunch
Share

Key takeaways

01

NASA successfully launched the most powerful rocket in the world into outer space this week.

02

The Orion spacecraft is headed for the moon, with the goal of returning to earth in less than four weeks.

03

The journey is the first leg of the Artemis I mission, which has the goal of eventually launching spacecraft…

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

NASA successfully launched the most powerful rocket in the world into outer space this week. The Orion spacecraft is headed for the moon, with the goal of returning to earth in less than four weeks.

The journey is the first leg of the Artemis I mission, which has the goal of eventually launching spacecraft from the moon to Mars.

Ryan Duffy, Managing Editor for Payload Space, explained that while this project was more expensive and took longer than expected, it is still a major milestone for NASA and the space exploration industry at large, whether future trips be government of privately funded.

Ryan’s Thoughts:

“This program was not without challenges. Super heavy SLS rocket came way over budget, years behind schedule, but NASA is back in the moonwalking business, or it will be soon, and the Artemis era is upon us. The big difference between Artemis and Apollo, I’d say is the prevalence and increased legitimacy of commercial space.

SpaceX will land at least two crews of Artemis astronauts on the moon. There’s a whole range of NASA-supported, but somewhat self-funded lunar landers and rovers that are headed for the lunar surface. The last thing to watch for toward the end of the decade is China and their moves around building a presence on the moon.

Another, longer-term thing to watch for is that we aren’t stopping on the moon. This time we’re headed for Mars as well.”

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

RD
Ryan DuffyManaging Editor

Ryan leads editorial operations at Payload, a new digital media outfit covering the business of policy of space. Payload's flagship product, a daily newsletter, features a combination of original reporting, news curation, and industry analysis.

B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

Verdel's Q-2DMS aims to bring 2D mass spectrometry to more common hardware

Verdel's Q-2DMS aims to bring 2D mass spectrometry to more common hardware

Verdel and Warwick have developed a version of two-dimensional mass spectrometry called Q-2DMS. Until now, only the best-funded centers could afford 2DMS hardware, and Verdel's chief executive argues that the field lacked access, not an understanding of what the method can do. If 2DMS moves onto more common hardware, more labs could evaluate it. Published results show up to tenfold more usable spectral information on closely related or near-isobaric compounds, the look-alike molecules that separation and filtering tend to blur together or drop.

  • 01The reported gain of up to tenfold more usable spectral information applies to closely related or near-isobaric compounds, so the best trial samples are the mixtures chromatography struggles to separate.
  • 02A complete time-stamped record can be revisited after a sample runs out or degrades, and a full acquisition could, in principle, let archived runs address new questions later.

Oct 9, 2026

Antibody developability checks are moving into discovery instead of waiting for development

Antibody developability checks are moving into discovery instead of waiting for development

Maria Gonzalez-Pajuelo of FairJourney Bio says the order in antibody discovery is changing: developability has become a much more important consideration during discovery, rather than an issue left until later-stage development. The goal, she says, is that what comes out of discovery is something CMC can take forward easily.

  • 01Discovery-stage developability screens can rank many antibodies tested once or twice and may reduce surprises later in development, while development still focuses on several lots of a single antibody and answers different questions.

Oct 1, 2026

Caraballo expects AI across all five tracks at ISPE’s 2026 Annual Meeting

Caraballo expects AI across all five tracks at ISPE’s 2026 Annual Meeting

ISPE’s 2026 Annual Meeting and Expo in Washington, DC organizes its program around five tracks running from discovery to governance, with international program committee chair Connie Langer of Pfizer Global Supply and executive chair Jose Caraballo of JCO Global Advisory LLC describing how the tracks connect—and why AI is treated as a cross-cutting topic rather than a standalone track. Deloitte’s December 2025 survey of 280 executives frames the mood the program is built for.

  • 01ISPE’s 2026 Annual Meeting has no dedicated AI track; executive chair Jose Caraballo expects AI presentations across all five tracks, from discovery to governance.
  • 02Deloitte’s December 2025 survey of 280 biopharma and medtech C-suite executives found more than 75% confident in their own outlook but only 41% optimistic about the global economy, a mood the story says the ISPE chairs are programming for.
  • 03A staffing firm reports life sciences job openings falling even as digital fluency becomes a required skill, so the upskilling burden lands on the people already employed, which is where the mandatory, university-partnered AI training Connie Langer describes at her company sits.

Sep 30, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

RD
Ryan Duffy

Managing Editor

Ryan leads editorial operations at Payload, a new digital media outfit covering the business of policy of space. Payload's flagship product, a daily newsletter, features a combination of original reporting, news curation, and industry analysis.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512